NCT00540163

Brief Summary

This observational non-interventional study is designed to demonstrate the improvement of physical function in COPD patients with exercise-induced dyspnoea on treatment with Spiriva (tiotropium 18 µg capsules) and allows adverse events to be recorded and evaluated.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,296

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

177 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2007

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 5, 2007

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2007

Completed
Last Updated

November 28, 2013

Status Verified

October 1, 2013

Enrollment Period

7 months

First QC Date

September 21, 2007

Last Update Submit

November 27, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint was the proportion of patients with an improvement by ≥10 points in the standardised PF-10 score after 6 weeks of treatment with Spiriva® 18 Microgram

    6 weeks

Secondary Outcomes (1)

  • The secondary endpoint was the change in the standardised PF-10 score within 6 weeks of treatment with Spiriva® 18 Microgram

    6 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients of office-based pulmonology practices

You may qualify if:

  • Men or women with COPD and a thoracic gas volume (TGV) of \< 140% at rest, MRC value of 2 or more.

You may not qualify if:

  • Patients cannot be recruited if any of the general or specific contraindications listed in the Patient information leaflet or the Summary of Product Characteristics applies.
  • Tiotropium bromide inhalation powder is contraindicated in patients with a hypersensitivity to tiotropium bromide, atropine or its derivatives, e.g. ipratropium or oxitropium or to the excipient lactose monohydrate which contains milk protein.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (177)

Boehringer Ingelheim Investigational Site

Amberg, Germany

Location

Boehringer Ingelheim Investigational Site

Anklam, Germany

Location

Boehringer Ingelheim Investigational Site

Aschau, Germany

Location

Boehringer Ingelheim Investigational Site

Auerbach, Germany

Location

Boehringer Ingelheim Investigational Site

Augsburg, Germany

Location

Boehringer Ingelheim Investigational Site

Backnang, Germany

Location

Boehringer Ingelheim Investigational Site

Bad Doberan, Germany

Location

Boehringer Ingelheim Investigational Site

Bad Lippspringe, Germany

Location

Boehringer Ingelheim Investigational Site

Bad Oeynhausen, Germany

Location

Boehringer Ingelheim Investigational Site

Bad Soden, Germany

Location

Boehringer Ingelheim Investigational Site

Bad Wörishofen, Germany

Location

Boehringer Ingelheim Investigational Site

Beelitz, Germany

Location

Boehringer Ingelheim Investigational Site

Bensheim, Germany

Location

Boehringer Ingelheim Investigational Site

Bergisch Gladbach, Germany

Location

Boehringer Ingelheim Investigational Site

Berlin, Germany

Location

Boehringer Ingelheim Investigational Site

Biberach, Germany

Location

Boehringer Ingelheim Investigational Site

Bochum, Germany

Location

Boehringer Ingelheim Investigational Site

Bonn, Germany

Location

Boehringer Ingelheim Investigational Site

Braunschweig, Germany

Location

Boehringer Ingelheim Investigational Site

Breisach, Germany

Location

Boehringer Ingelheim Investigational Site

Bremen, Germany

Location

Boehringer Ingelheim Investigational Site

Bremerhaven, Germany

Location

Boehringer Ingelheim Investigational Site

Bruchsal, Germany

Location

Boehringer Ingelheim Investigational Site

Buchholz, Germany

Location

Boehringer Ingelheim Investigational Site

Bünde, Germany

Location

Boehringer Ingelheim Investigational Site

Calw, Germany

Location

Boehringer Ingelheim Investigational Site

Castrop-Rauxel, Germany

Location

Boehringer Ingelheim Investigational Site

Celle, Germany

Location

Boehringer Ingelheim Investigational Site

Chemnitz, Germany

Location

Boehringer Ingelheim Investigational Site

Coburg, Germany

Location

Boehringer Ingelheim Investigational Site

Cologne, Germany

Location

Boehringer Ingelheim Investigational Site

Cottbus, Germany

Location

Boehringer Ingelheim Investigational Site

Darmstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Dillenburg, Germany

Location

Boehringer Ingelheim Investigational Site

Dinslaken, Germany

Location

Boehringer Ingelheim Investigational Site

Dortmund, Germany

Location

Boehringer Ingelheim Investigational Site

Dresden, Germany

Location

Boehringer Ingelheim Investigational Site

Duisburg, Germany

Location

Boehringer Ingelheim Investigational Site

Düren, Germany

Location

Boehringer Ingelheim Investigational Site

Düsseldorf, Germany

Location

Boehringer Ingelheim Investigational Site

Eisenhüttenstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Emden, Germany

Location

Boehringer Ingelheim Investigational Site

Erbach im Odenwald, Germany

Location

Boehringer Ingelheim Investigational Site

Erfurt, Germany

Location

Boehringer Ingelheim Investigational Site

Essen, Germany

Location

Boehringer Ingelheim Investigational Site

Esslingen am Neckar, Germany

Location

Boehringer Ingelheim Investigational Site

Euskirchen, Germany

Location

Boehringer Ingelheim Investigational Site

Fellbach, Germany

Location

Boehringer Ingelheim Investigational Site

Flensburg, Germany

Location

Boehringer Ingelheim Investigational Site

Forchheim, Germany

Location

Boehringer Ingelheim Investigational Site

Frankfurt, Germany

Location

Boehringer Ingelheim Investigational Site

Freising, Germany

Location

Boehringer Ingelheim Investigational Site

Fürstenfeldbruck, Germany

Location

Boehringer Ingelheim Investigational Site

Fürth, Germany

Location

Boehringer Ingelheim Investigational Site

Gadebusch, Germany

Location

Boehringer Ingelheim Investigational Site

Geilenkirchen, Germany

Location

Boehringer Ingelheim Investigational Site

Gelnhausen, Germany

Location

Boehringer Ingelheim Investigational Site

Gelsenkirchen, Germany

Location

Boehringer Ingelheim Investigational Site

Germering, Germany

Location

Boehringer Ingelheim Investigational Site

Giessen, Germany

Location

Boehringer Ingelheim Investigational Site

Gifhorn, Germany

Location

Boehringer Ingelheim Investigational Site

Gotha, Germany

Location

Boehringer Ingelheim Investigational Site

Göppingen, Germany

Location

Boehringer Ingelheim Investigational Site

Greiz, Germany

Location

Boehringer Ingelheim Investigational Site

Gummersbach, Germany

Location

Boehringer Ingelheim Investigational Site

Gütersloh, Germany

Location

Boehringer Ingelheim Investigational Site

Halberstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Halle, Germany

Location

Boehringer Ingelheim Investigational Site

Hamburg, Germany

Location

Boehringer Ingelheim Investigational Site

Hamelin, Germany

Location

Boehringer Ingelheim Investigational Site

Hamm, Germany

Location

Boehringer Ingelheim Investigational Site

Hanover, Germany

Location

Boehringer Ingelheim Investigational Site

Heidelberg, Germany

Location

Boehringer Ingelheim Investigational Site

Heilbronn, Germany

Location

Boehringer Ingelheim Investigational Site

Herne, Germany

Location

Boehringer Ingelheim Investigational Site

Hilden, Germany

Location

Boehringer Ingelheim Investigational Site

Hildesheim, Germany

Location

Boehringer Ingelheim Investigational Site

Hoyerswerda, Germany

Location

Boehringer Ingelheim Investigational Site

Ibbenbueren, Germany

Location

Boehringer Ingelheim Investigational Site

Ingolstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Iserlohn, Germany

Location

Boehringer Ingelheim Investigational Site

Kaiserslautern, Germany

Location

Boehringer Ingelheim Investigational Site

Kamen, Germany

Location

Boehringer Ingelheim Investigational Site

Karlsruhe, Germany

Location

Boehringer Ingelheim Investigational Site

Kaufbeuren, Germany

Location

Boehringer Ingelheim Investigational Site

Kempten, Germany

Location

Boehringer Ingelheim Investigational Site

Kevelaer, Germany

Location

Boehringer Ingelheim Investigational Site

Kiel, Germany

Location

Boehringer Ingelheim Investigational Site

Konstanz, Germany

Location

Boehringer Ingelheim Investigational Site

Krefeld, Germany

Location

Boehringer Ingelheim Investigational Site

Landshut, Germany

Location

Boehringer Ingelheim Investigational Site

Langenfeld, Germany

Location

Boehringer Ingelheim Investigational Site

Leipzig, Germany

Location

Boehringer Ingelheim Investigational Site

Limburg, Germany

Location

Boehringer Ingelheim Investigational Site

Lindenberg, Germany

Location

Boehringer Ingelheim Investigational Site

Linz, Germany

Location

Boehringer Ingelheim Investigational Site

Lippstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Loerrach, Germany

Location

Boehringer Ingelheim Investigational Site

Ludwigsburg, Germany

Location

Boehringer Ingelheim Investigational Site

Lüdenscheid, Germany

Location

Boehringer Ingelheim Investigational Site

Lüneburg, Germany

Location

Boehringer Ingelheim Investigational Site

Magdeburg, Germany

Location

Boehringer Ingelheim Investigational Site

Mainz, Germany

Location

Boehringer Ingelheim Investigational Site

Marburg, Germany

Location

Boehringer Ingelheim Investigational Site

Markkleeberg, Germany

Location

Boehringer Ingelheim Investigational Site

Memmingen, Germany

Location

Boehringer Ingelheim Investigational Site

Menden, Germany

Location

Boehringer Ingelheim Investigational Site

Minden, Germany

Location

Boehringer Ingelheim Investigational Site

Moers, Germany

Location

Boehringer Ingelheim Investigational Site

Mönchengladbach, Germany

Location

Boehringer Ingelheim Investigational Site

Mühldorf, Germany

Location

Boehringer Ingelheim Investigational Site

Mülheim, Germany

Location

Boehringer Ingelheim Investigational Site

München, Germany

Location

Boehringer Ingelheim Investigational Site

Neu-Ulm, Germany

Location

Boehringer Ingelheim Investigational Site

Neunkirchen, Germany

Location

Boehringer Ingelheim Investigational Site

Norderstedt, Germany

Location

Boehringer Ingelheim Investigational Site

Nordhausen, Germany

Location

Boehringer Ingelheim Investigational Site

Nuremberg, Germany

Location

Boehringer Ingelheim Investigational Site

Oberursel, Germany

Location

Boehringer Ingelheim Investigational Site

Olpe, Germany

Location

Boehringer Ingelheim Investigational Site

Oschersleben, Germany

Location

Boehringer Ingelheim Investigational Site

Osnabrück, Germany

Location

Boehringer Ingelheim Investigational Site

Papenburg, Germany

Location

Boehringer Ingelheim Investigational Site

Peine, Germany

Location

Boehringer Ingelheim Investigational Site

Plauen, Germany

Location

Boehringer Ingelheim Investigational Site

Potsdam, Germany

Location

Boehringer Ingelheim Investigational Site

Pulheim, Germany

Location

Boehringer Ingelheim Investigational Site

Rastatt, Germany

Location

Boehringer Ingelheim Investigational Site

Rathenow, Germany

Location

Boehringer Ingelheim Investigational Site

Regensburg, Germany

Location

Boehringer Ingelheim Investigational Site

Remscheid, Germany

Location

Boehringer Ingelheim Investigational Site

Rendsburg, Germany

Location

Boehringer Ingelheim Investigational Site

Rostock, Germany

Location

Boehringer Ingelheim Investigational Site

Rüdersdorf, Germany

Location

Boehringer Ingelheim Investigational Site

Rüsselsheim am Main, Germany

Location

Boehringer Ingelheim Investigational Site

Saarbrücken, Germany

Location

Boehringer Ingelheim Investigational Site

Saarlouis, Germany

Location

Boehringer Ingelheim Investigational Site

Salzgitter, Germany

Location

Boehringer Ingelheim Investigational Site

Schenefeld, Germany

Location

Boehringer Ingelheim Investigational Site

Schleswig, Germany

Location

Boehringer Ingelheim Investigational Site

Schmölln, Germany

Location

Boehringer Ingelheim Investigational Site

Schwalmstadt, Germany

Location

Boehringer Ingelheim Investigational Site

Schwalmtal, Germany

Location

Boehringer Ingelheim Investigational Site

Schwerin, Germany

Location

Boehringer Ingelheim Investigational Site

Sebnitz, Germany

Location

Boehringer Ingelheim Investigational Site

Seevetal, Germany

Location

Boehringer Ingelheim Investigational Site

Siegen, Germany

Location

Boehringer Ingelheim Investigational Site

Singen, Germany

Location

Boehringer Ingelheim Investigational Site

Sinsheim, Germany

Location

Boehringer Ingelheim Investigational Site

Solingen, Germany

Location

Boehringer Ingelheim Investigational Site

Sonneberg, Germany

Location

Boehringer Ingelheim Investigational Site

Spremberg, Germany

Location

Boehringer Ingelheim Investigational Site

Stade, Germany

Location

Boehringer Ingelheim Investigational Site

Starnberg, Germany

Location

Boehringer Ingelheim Investigational Site

Steinbach, Germany

Location

Boehringer Ingelheim Investigational Site

Straelen, Germany

Location

Boehringer Ingelheim Investigational Site

Strausberg, Germany

Location

Boehringer Ingelheim Investigational Site

Stuttgart, Germany

Location

Boehringer Ingelheim Investigational Site

Teltow, Germany

Location

Boehringer Ingelheim Investigational Site

Teterow, Germany

Location

Boehringer Ingelheim Investigational Site

Troisdorf, Germany

Location

Boehringer Ingelheim Investigational Site

Unna, Germany

Location

Boehringer Ingelheim Investigational Site

Uttenreuth, Germany

Location

Boehringer Ingelheim Investigational Site

Verden an der Aller, Germany

Location

Boehringer Ingelheim Investigational Site

Waiblingen, Germany

Location

Boehringer Ingelheim Investigational Site

Waren, Germany

Location

Boehringer Ingelheim Investigational Site

Warendorf, Germany

Location

Boehringer Ingelheim Investigational Site

Weiden, Germany

Location

Boehringer Ingelheim Investigational Site

Weißenhorn, Germany

Location

Boehringer Ingelheim Investigational Site

Wetzlar, Germany

Location

Boehringer Ingelheim Investigational Site

Wiesloch, Germany

Location

Boehringer Ingelheim Investigational Site

Wilhelmshaven, Germany

Location

Boehringer Ingelheim Investigational Site

Witten, Germany

Location

Boehringer Ingelheim Investigational Site

Worms, Germany

Location

Boehringer Ingelheim Investigational Site

Wuppertal, Germany

Location

Boehringer Ingelheim Investigational Site

Zella-Mehlis, Germany

Location

Boehringer Ingelheim Investigational Site

Zossen, Germany

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Boehringer Ingelheim

    Boehringer Ingelheim

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 21, 2007

First Posted

October 5, 2007

Study Start

April 1, 2007

Primary Completion

November 1, 2007

Last Updated

November 28, 2013

Record last verified: 2013-10

Locations